NP04634 prevents cell damage caused by calcium overload and mitochondrial disruption in bovine chromaffin cells

European Journal of Pharmacology

Volumn 607, Issue 1-3, 2009, Pages 47-53

  Valero, Teresa ^a,b   del Barrio, Laura ^a,b   Egea, Javier ^a,b   Cañas, Noelia ^a,b   Martínez, Ana ^d   García, Antonio G ^a,b,c   Villarroya, Mercedes ^a,b   López, Manuela G ^a,b  

^a INSTITUTO TEÓFILO HERNANDO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Noscira   (Spain)

Author keywords

Chromaffin cells; Cytoprotection; Intracellular calcium; NP04634; Oxidative stress; Veratridine

Indexed keywords

4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; CALCIUM; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; NIMODIPINE; NP 04634; OLIGOMYCIN; OMEGA CONOTOXIN MVIIC; POTASSIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; UNCLASSIFIED DRUG; VERATRIDINE; VOLTAGE GATED CALCIUM CHANNEL;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL DEATH; CELL DISRUPTION; CELL PROTECTION; CHROMAFFIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; CYTOTOXICITY; DEPOLARIZATION; DRUG EFFECT; MITOCHONDRION; NERVE CELL; NEUROPROTECTION; NONHUMAN; OSCILLATION; PRIORITY JOURNAL;

ANIMALS; BENZAMIDES; CALCIUM; CALCIUM CHANNELS, L-TYPE; CATTLE; CELL DEATH; CELLS, CULTURED; CHROMAFFIN CELLS; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; MITOCHONDRIA; PORIFERA; PROTECTIVE AGENTS;

EID: 62149130068     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.02.021     Document Type: Article

References (35)

1. Ansari M.A., Joshi G., Huang Q., Opii W.O., Abdul H.M., Sultana R., and Butterfield D.A. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders. Free Radic. Biol. Med. 41 (2006) 1694-1703
2. Arias E., Ales E., Gabilan N.H., Cano-Abad M.F., Villarroya M., Garcia A.G., and Lopez M.G. Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46 (2004) 103-114
3. Beatrice M.C., Palmer J.W., and Pfeiffer D.R. The relationship between mitochondrial membrane permeability, membrane potential, and the retention of Ca2+ by mitochondria. J. Biol. Chem. 255 (1980) 8663-8671
4. Canas N., Valero T., Villarroya M., Montell E., Verges J., Garcia A.G., and Lopez M.G. Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/Akt. J. Pharmacol. Exp. Ther. 323 (2007) 946-953
5. Cano-Abad M.F., Lopez M.G., Hernandez-Guijo J.M., Zapater P., Gandia L., Sanchez-Garcia P., and Garcia A.G. Effects of the neuroprotectant lubeluzole on the cytotoxic actions of veratridine, barium, ouabain and 6-hydroxydopamine in chromaffin cells. Br. J. Pharmacol. 124 (1998) 1187-1196
6. Cano-Abad M.F., Villarroya M., Garcia A.G., Gabilan N.H., and Lopez M.G. Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death. J. Biol. Chem. 276 (2001) 39,695-39,704
7. Carter N.J., and Keam S.J. Trabectedin: a review of its use in the management of soft tissue sarcoma and ovarian cancer. Drugs 67 (2007) 2257-2276
8. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
9. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18 (1995) 58-60
10. Dembitsky V.M., Gloriozova T.A., and Poroikov V.V. Novel antitumor agents: marine sponge alkaloids, their synthetic analogs and derivatives. Mini Rev. Med. Chem. 5 (2005) 319-336
11. Duchen M.R. Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death. J. Physiol. 516 Pt 1 (1999) 1-17
12. Egea J., Hernandez-Guijo J.M., Olivares R., Lopez M.G., and Garcia A.G. Desensitized nicotinic receptors that, however, afford cytoprotection in bovine chromaffin cells. J. Mol. Neurosci. 30 (2006) 59-60
13. Garcia A.G., Garcia-De-Diego A.M., Gandia L., Borges R., and Garcia-Sancho J. Calcium signaling and exocytosis in adrenal chromaffin cells. Physiol. Rev. 86 (2006) 1093-1131
14. Gunter T.E., and Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258 (1990) C755-786
15. Jordan J., Galindo M.F., Calvo S., Gonzalez-Garcia C., and Cena V. Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production. Br. J. Pharmacol. 130 (2000) 1496-1504
16. Jordan J., Galindo M.F., Tornero D., Benavides A., Gonzalez C., Agapito M.T., Gonzalez-Garcia C., and Cena V. Superoxide anions mediate veratridine-induced cytochrome c release and caspase activity in bovine chromaffin cells. Br. J. Pharmacol. 137 (2002) 993-1000
17. Kim S., and Rhim H. Ginsenosides inhibit NMDA receptor-mediated epileptic discharges in cultured hippocampal neurons. Arch. Pharm. Res. 27 (2004) 524-530
18. Korotzer A.R., Whittemore E.R., and Cotman C.W. Differential regulation by beta-amyloid peptides of intracellular free Ca2+ concentration in cultured rat microglia. Eur. J. Pharmacol. 288 (1995) 125-130
19. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
20. Livett B.G. Adrenal medullary chromaffin cells in vitro. Physiol. Rev. 64 (1984) 1103-1161
21. Lopez M.G., Artalejo A.R., Garcia A.G., Neher E., and Garcia-Sancho J. Veratridine-induced oscillations of cytosolic calcium and membrane potential in bovine chromaffin cells. J. Physiol. 482 Pt 1 (1995) 15-27
22. Maroto R., De la Fuente M.T., Artalejo A.R., Abad F., Lopez M.G., Garcia-Sancho J., and Garcia A.G. Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine. Eur. J. Pharmacol. 270 (1994) 331-339
23. Maroto R., de la Fuente M.T., Zapater P., Abad F., Esquerro E., and Garcia A.G. Effects of omega-conotoxin MVIIC on veratridine-induced cytotoxicity and cytosolic Ca(2+) oscillations. Brain Res. 714 (1996) 209-214
24. Moro M.A., Lopez M.G., Gandia L., Michelena P., and Garcia A.G. Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae. Anal. Biochem. 185 (1990) 243-248
25. Ohta S., Smith M.L., and Siesjo B.K. The effect of a dihydropyridine calcium antagonist (isradipine) on selective neuronal necrosis. J. Neurol. Sci. 103 (1991) 109-115
26. Pauwels P.J., Van Assouw H.P., Leysen J.E., and Janssen P.A. Ca2+-mediated neuronal death in rat brain neuronal cultures by veratridine: protection by flunarizine. Mol. Pharmacol. 36 (1989) 525-531
27. Sattler R., and Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 78 (2000) 3-13
28. Schinder A.F., Olson E.C., Spitzer N.C., and Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16 (1996) 6125-6133
29. Sipkema D., Franssen M.C., Osinga R., Tramper J., and Wijffels R.H. Marine sponges as pharmacy. Mar. Biotechnol. (NY) 7 (2005) 142-162
30. Small D.L., Monette R., Buchan A.M., and Morley P. Identification of calcium channels involved in neuronal injury in rat hippocampal slices subjected to oxygen and glucose deprivation. Brain Res. 753 (1997) 209-218
31. Sobrado M., Lopez M.G., Carceller F., Garcia A.G., and Roda J.M. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia. Neuroscience 118 (2003) 107-113
32. Steen P.A., Newberg L.A., Milde J.H., and Michenfelder J.D. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J. Cereb. Blood Flow Metab. 4 (1984) 82-87
33. Trushina E., and McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145 (2007) 1233-1248
34. Valentino K., Newcomb R., Gadbois T., Singh T., Bowersox S., Bitner S., Justice A., Yamashiro D., Hoffman B.B., Ciaranello R., et al. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7894-7897
35. Villarroya M., Garcia A.G., Marco-Contelles J., and Lopez M.G. An update on the pharmacology of galantamine. Expert Opin. Investig. Drugs 16 (2007) 1987-1998